PODCAST: Kari Nadeau, MD, PhD discusses her work on oral immunotherapy with children

Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings.

In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months.

The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.

A recent study highlights potential reductions in macronutrient levels in breast milk because of maternal medications, though breastfeeding remains strongly recommended.